Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Hyperphosphatemia In Chronic Kidney Disease - Overview
Hyperphosphatemia In Chronic Kidney Disease - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Hyperphosphatemia In Chronic Kidney Disease - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Hyperphosphatemia In Chronic Kidney Disease - Companies Involved in Therapeutics Development
Ardelyx Inc
Citragen Pharmaceuticals Inc
OPKO Health Inc
Panion & Bf Biotech Inc
Shield Therapeutics Plc
Unicycive Therapeutics Inc
Vidasym Inc
Hyperphosphatemia In Chronic Kidney Disease - Drug Profiles
Hyperphosphatemia In Chronic Kidney Disease - Dormant Projects
Hyperphosphatemia In Chronic Kidney Disease - Discontinued Products
Hyperphosphatemia In Chronic Kidney Disease - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Hyperphosphatemia In Chronic Kidney Disease, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Targets, H2 2019
Number of Products by Stage and Targets, H2 2019
Number of Products by Mechanism of Actions, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Molecule Types, H2 2019
Number of Products by Stage and Molecule Types, H2 2019


List of Tables


Number of Products under Development for Hyperphosphatemia In Chronic Kidney Disease, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Universities/Institutes, H2 2019
Products under Development by Companies, H2 2019
Products under Development by Universities/Institutes, H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Hyperphosphatemia In Chronic Kidney Disease - Pipeline by Ardelyx Inc, H2 2019
Hyperphosphatemia In Chronic Kidney Disease - Pipeline by Citragen Pharmaceuticals Inc, H2 2019
Hyperphosphatemia In Chronic Kidney Disease - Pipeline by OPKO Health Inc, H2 2019
Hyperphosphatemia In Chronic Kidney Disease - Pipeline by Panion & Bf Biotech Inc, H2 2019
Hyperphosphatemia In Chronic Kidney Disease - Pipeline by Shield Therapeutics Plc, H2 2019
Hyperphosphatemia In Chronic Kidney Disease - Pipeline by Unicycive Therapeutics Inc, H2 2019
Hyperphosphatemia In Chronic Kidney Disease - Pipeline by Vidasym Inc, H2 2019
Hyperphosphatemia In Chronic Kidney Disease - Dormant Projects, H2 2019
Hyperphosphatemia In Chronic Kidney Disease - Discontinued Products, H2 2019